Cholestech to Present at the Roth Capital Partners 2006 New York Investor Conference
01 September 2006 - 12:49AM
PR Newswire (US)
HAYWARD, Calif., Aug. 31 /PRNewswire-FirstCall/ -- Cholestech
Corporation (NASDAQ:CTEC), a leading manufacturer of point of care
testing devices, today announced that Warren E. Pinckert II,
President and CEO, and Jack Glenn, CFO, will present at the Roth
Capital Partners' 2006 New York Investor Conference on Thursday,
September 7, 2006, at 10:00 a.m. Eastern Time in New York City, New
York. The presentation will include an overview of the company,
current products, product pipeline and recent financial
performance; and will be webcast and accessible on Cholestech's
website at http://www.cholestech.com/ . About Cholestech Cholestech
is committed to enabling people to lead longer, healthier and more
active lives. Cholestech provides easy to use, accessible
diagnostic tools and information to health care practitioners in
over 35 countries around the world. Cholestech offers efficient and
economic diagnostic testing for cholesterol and related lipids,
blood glucose and glycemic control, and liver enzymes at the point
of care. Health care providers can use the CLIA-waived Cholestech
LDX(R) and GDX(TM) Systems and the hs-CRP test, which is cleared by
the FDA for use in moderate complexity labs, to initiate and
monitor the progress of patient therapy. By providing effective
disease management solutions, Cholestech's goal is to be a leading
provider of diagnostic tools and information for immediate risk
assessment and therapeutic monitoring of heart disease and
diabetes. Cholestech LDX(R) is a registered trademark and
Cholestech GDX(TM) is a trademark of Cholestech Corporation. All
other trademarks mentioned in this document are the property of
their respective owners. For more information about Cholestech and
its products visit us on the web at http://www.cholestech.com/ .
DATASOURCE: Cholestech Corporation CONTACT: Jack Glenn, Chief
Financial Officer of Cholestech Corporation, +1-510-781-5065, or ;
or investors, Brendan Lahiff of Financial Dynamics,
+1-415-439-4504, or , for Cholestech Corporation Web site:
http://www.cholestech.com/
Copyright
Global X CleanTech ETF (NASDAQ:CTEC)
Historical Stock Chart
Von Dez 2024 bis Jan 2025
Global X CleanTech ETF (NASDAQ:CTEC)
Historical Stock Chart
Von Jan 2024 bis Jan 2025
Echtzeit-Nachrichten über Global X CleanTech ETF (NASDAQ): 0 Nachrichtenartikel
Weitere Cholestech (MM) News-Artikel